Evidence map›Paper›PMID 42042173›Full record

ReviewGels (Basel, Switzerland)2026

Designing Multifunctional Antibacterial Hydrogels: A Tri-Pillar Approach Based on Bacteriophages, Hydroxyapatite, and Electrospun Systems.

Jordi Puiggalí

Abstract readReview
In one paragraph

Review in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jordi PuiggalíDepartament de Enginyeria Química, Escola d'Enginyeria de Barcelona Est, Universitat Politècnica de Catalunya, Av. Eduard Maristany 10-14, 08019 Barcelona, Spain.ORCID 0000-0002-0640-4474

Funding

Generalitat de Catalunya 2021-SGR-01042Ministry of Science and Information PID2022-140302OB-I00
6 · The paper itself

Abstract

The rapid emergence of antibiotic-resistant bacteria represents one of the most critical challenges in modern healthcare and has stimulated intense research into alternative antimicrobial strategies. Antibacterial hydrogels have emerged as versatile biomaterials due to their high water content, tunable physicochemical properties, and ability to function as multifunctional platforms for drug delivery and tissue regeneration. This review analyzes recent advances in antibacterial hydrogel systems through a conceptual framework based on three complementary pillars: biological antibacterial agents, inorganic functional components, and structural material engineering. Biological strategies, particularly bacteriophage-based approaches, provide highly specific antibacterial activity capable of targeting multidrug-resistant pathogens and disrupting bacterial biofilms. Inorganic components such as hydroxyapatite nanoparticles contribute additional functionalities including drug adsorption, modulation of the ionic microenvironment, and osteoconductive behavior relevant for bone-related infections. Structural design strategies based on electrospinning enable the fabrication of fibrous architectures that enhance mechanical stability, regulate therapeutic release, and mimic extracellular matrix organization. The integration of these three pillars within multifunctional hydrogel platforms offers promising opportunities for developing advanced antibacterial biomaterials capable of addressing infection control while supporting tissue regeneration.

Indexed as

antibacterial hydrogelsantimicrobial materialsbacteriophagesbiofilm infectionsdrug delivery systemselectrospinninghydroxyapatite nanoparticlesmultifunctional biomaterialstissue regeneration

Identifiers

PMID42042173
PMCPMC13116595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.